SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-273038
Filing Date
2019-10-24
Accepted
2019-10-24 06:47:09
Documents
14
Period of Report
2019-10-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d820666d8k.htm   iXBRL 8-K 41261
2 EX-99.1 d820666dex991.htm EX-99.1 36019
6 GRAPHIC g820666g1023161316356.jpg GRAPHIC 4139
  Complete submission text file 0001193125-19-273038.txt   208925

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbm-20191023.xsd EX-101.SCH 3065
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbm-20191023_lab.xml EX-101.LAB 17375
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbm-20191023_pre.xml EX-101.PRE 10951
14 EXTRACTED XBRL INSTANCE DOCUMENT d820666d8k_htm.xml XML 3305
Mailing Address ONE MEADOWLANDS PLAZA E. RUTHERFORD NJ 07073
Business Address ONE MEADOWLANDS PLZ E RUTHERFORD NJ 07073 2018043000
CAMBREX CORP (Filer) CIK: 0000820081 (see all company filings)

IRS No.: 222476135 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10638 | Film No.: 191164773
SIC: 2834 Pharmaceutical Preparations